Lingyin Ge, PhD
(she/her/hers)Overview
Lingyin Ge assists the Biotechnology Practice in US and foreign patent preparation and prosecution, freedom-to-operate analysis, IP landscape analysis, and due diligence. She draws from her scientific background when assisting life sciences clients, including start-ups, mid-large size companies, and research institutions, with their intellectual property needs.
Lingyin has extensive knowledge in the areas of gene therapy, antibodies, therapeutic peptides, antisense oligonucleotides, and biomolecule production.
Prior to joining Wolf Greenfield, Lingyin was a project scientist at Cedars-Sinai Medical Center. She conducted research on pulmonary fibrosis and lung injury. Lingyin also interned in the tech transfer office at Cedars-Sinai, where she evaluated patentability and marketability of disclosed therapeutic and medical device inventions and assisted external legal counsel in drafting patent applications and office action responses.
Lingyin received her PhD from Stony Brook University. Her research focused on DBP-Actin complex serves as Danger Associated Molecular Pattern (DAMPs) to induce acute lung injury in sepsis and trauma patients.
Experience
- Assisted a leading pharmaceutical company to maintain and improve a patent portfolio and develop global prosecution strategy inline with client’s commercial interests
- Assisted a start-up biotech company to build and expand patent portfolios to various programs
Activities
- Boston Intellectual Property Law Association
Interests
I’m a zealous collector of minerals, gemstones, and rocks.